Parent Interventions: Fast food restaurant proximity likely doesn't affect children's weight   |  Parent Interventions: Families' remote learning experience during lockdown positive   |  Health Monitor: Helplines are Open  |  National Edu News: Dr Harsh Vardhan inaugurates the new entity CSIR-NIScPR  |  National Edu News: Remarkable indigenous technologies developed during the Covid pandemic   |  National Edu News: PM to launch Pan India Rollout of COVID-19 Vaccination drive on 16 January  |  Science Innovations: Sunscreen Lotions May Cause Breast Cancer  |  Leadership Instincts: Multi-Level School Leadership for Building Trust, Collaboration and Innovation  |  Leadership Instincts: Tsinghua teachers win “Renowned Teacher” Awards  |  Teacher Insights: NIC and CBSE to launch CollabCAD Software  |  National Edu News: Union Education Minister reviews implementation of New Education Policy- 2020  |  Policy Indications: Circular Economy, a New Book on Resource Utilisation and Sustainability  |  Teacher Insights: Flip not Flop  |  Teacher Insights: EPFL student creates a new language-analysis programme  |  Science Innovations: NUS researchers concoct probiotic coffee and tea drinks  |  
April 23, 2020 Thursday 03:57:35 PM IST

First Artificial Pancreas App

International Edu News

The University of Cambridge has developed the world's first downloadable artificial pancreas app for people with type 1 diabetes. The CamAPS FX app works with an insulin pump and a glucose monitor to automatically deliver insulin to people living with the condition via a complex algorithm. The app was developed based on over a decade of research by Professor Roman Hovorka.It will be useful in patients who experience potentially dangerous low blood glucose levels at night. The app can also upload the user’s blood glucose measurements seamlessly to Diasend, an online platform, allowing their diabetes team to provide more personalised care.The app is now available for UK users to download onto Android phones via the Amazon Appstore. The app is available on a subscription basis starting at £70 per month.It is licensed for use by both adults and children with the condition and is the first artificial pancreas system to be licensed for use in pregnancy, or by young children aged one and above.

Comments